Caffeic acid and diseases—Mechanisms of action

N Pavlíková - International Journal of Molecular Sciences, 2022 - mdpi.com
Caffeic acid belongs to the polyphenol compounds we consume daily, often in the form of
coffee. Even though it is less explored than caffeic acid phenethyl ester, it still has many …

Alzheimer's disease: updated multi-targets therapeutics are in clinical and in progress

Z Sang, K Wang, J Dong, L Tang - European journal of medicinal chemistry, 2022 - Elsevier
Alzheimer's disease is a chronic and progressive brain neurodegenerative disease affecting
over 30 million people globally. Currently, no effective treatment is available due to multiple …

Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement

GD Stanciu, A Luca, RN Rusu, V Bild… - Biomolecules, 2019 - mdpi.com
Alzheimer's disease, a major and increasing global health challenge, is an irreversible,
progressive form of dementia, associated with an ongoing decline of brain functioning. The …

Sulfonamide derivatives as multi-target agents for complex diseases

S Apaydın, M Török - Bioorganic & medicinal chemistry letters, 2019 - Elsevier
Sulfonamide derivatives are frequently seen structural motifs in medicinal chemistry. Almost
a century after Gerhard Domagk's pioneering work leading to the first sulfonamide antibiotic …

Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism

S Xing, Q Li, B Xiong, Y Chen, F Feng… - Medicinal Research …, 2021 - Wiley Online Library
Structural information of butyrylcholinesterase (BChE) and its variants associated with
several diseases are discussed here. Pure human BChE has been proved safe and effective …

Medicinal chemistry of indane and its analogues: A mini review

P Prasher, M Sharma - ChemistrySelect, 2021 - Wiley Online Library
Abstract 'Indane′ and its analogues indene, 1‐indenone, and 1, 3‐indandione present an
attractive biological profile for the rational development of therapeutic molecules. The …

Discovery of potent cholinesterase inhibition-based multi-target-directed lead compounds for synaptoprotection in Alzheimer's disease

B Turgutalp, P Bhattarai, T Ercetin, C Luise… - Journal of medicinal …, 2022 - ACS Publications
Drug development efforts that focused on single targets failed to provide effective treatment
for Alzheimer's disease (AD). Therefore, we designed cholinesterase inhibition (ChEI) …

Selective pseudo-irreversible butyrylcholinesterase inhibitors transferring antioxidant moieties to the enzyme show pronounced neuroprotective efficacy in vitro and in …

M Scheiner, M Hoffmann, F He, E Poeta… - Journal of Medicinal …, 2021 - ACS Publications
A series of multitarget-directed ligands (MTDLs) was designed by functionalizing a pseudo-
irreversible butyrylcholinesterase (BChE) inhibitor. The obtained hybrids were investigated …

Design, synthesis, and biological evaluation of novel (4-(1, 2, 4-oxadiazol-5-yl) phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of …

T Liu, S Chen, J Du, S Xing, R Li, Z Li - European journal of medicinal …, 2022 - Elsevier
On the basis of our previous work, a novel series of (4-(1, 2, 4-oxadiazol-5-yl) phenyl)-2-
aminoacetamide derivatives were synthesized and evaluated as multifunctional ligands for …

Neuroprotective effect of terpenoids recovered from olive oil by-products

ZJ Suárez Montenegro, G Álvarez-Rivera… - Foods, 2021 - mdpi.com
The neuroprotective potential of 32 natural extracts obtained from olive oil by-products was
investigated. The online coupling of supercritical fluid extraction (SFE) and dynamic …